Related Experiment Video
Updated: Jul 19, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Establishing key performance indicators for inflammatory bowel disease in the UK
Mohammed Nabil Quraishi1, Elizabeth Dobson2, Rachel Ainley3
1Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
This study established key performance indicators (KPIs) to standardize Inflammatory Bowel Disease (IBD) care across the UK. These benchmarks aim to improve quality and reduce variations in patient treatment and outcomes.
Area of Science:
- Gastroenterology
- Healthcare Quality Improvement
- Clinical Audit
Background:
- Inflammatory Bowel Disease (IBD) UK National Audits revealed significant variations in patient care.
- A need was identified to establish clear standards for optimal IBD care delivery.
Purpose of the Study:
- To develop and validate Key Performance Indicators (KPIs) for benchmarking IBD care in the UK.
- To create reliable metrics for assessing and improving the quality of IBD services.
Main Methods:
- Stakeholder meetings identified critical patient journey aspects for KPIs.
- A two-stage Delphi consensus involving multidisciplinary teams and patient representatives refined KPI definitions and methodology.
- Gastroenterology services across the UK surveyed for feasibility and utility assessment.
Main Results:
- Four core KPIs were refined, focusing on diagnostic timelines, treatment initiation, and appropriate use of steroids and advanced therapies.
- Over 85% agreement was reached on the feasibility of adopting the quality improvement (QI) process locally.
- More than 75% agreement confirmed the utility of benchmarking these KPIs.
Conclusions:
- Quantifiable KPIs have been proposed through a structured consensus approach.
- These KPIs will facilitate benchmarking to enhance IBD care quality and minimize variations across the UK.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

